Literature DB >> 23734005

An update on immune system activation in the pathogenesis of hypertension.

Michael J Ryan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23734005      PMCID: PMC4365420          DOI: 10.1161/HYPERTENSIONAHA.113.00603

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  58 in total

1.  Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Authors:  Talin Ebrahimian; Melissa Wei Li; Catherine A Lemarié; Stefania M C Simeone; Patrick J Pagano; Matthias Gaestel; Pierre Paradis; Sven Wassmann; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

2.  NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.

Authors:  D N Muller; R Dechend; E M Mervaala; J K Park; F Schmidt; A Fiebeler; J Theuer; V Breu; D Ganten; H Haller; F C Luft
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

3.  Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension.

Authors:  Dong-Jie Li; Roger G Evans; Zhong-Wei Yang; Shu-Wei Song; Pei Wang; Xiu-Juan Ma; Chong Liu; Tao Xi; Ding-Feng Su; Fu-Ming Shen
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

4.  Blood pressure and inflammation in apparently healthy men.

Authors:  C U Chae; R T Lee; N Rifai; P M Ridker
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

5.  Transforming growth factor beta in hypertensives with cardiorenal damage.

Authors:  C Laviades; N Varo; J Díez
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

6.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

Authors:  B Rodríguez-Iturbe; H Pons; Y Quiroz; K Gordon; J Rincón; M Chávez; G Parra; J Herrera-Acosta; D Gómez-Garre; R Largo; J Egido; R J Johnson
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.

Authors:  Christopher T Chan; Jeffrey P Moore; Klaudia Budzyn; Elizabeth Guida; Henry Diep; Antony Vinh; Emma S Jones; Robert E Widdop; James A Armitage; Samy Sakkal; Sharon D Ricardo; Christopher G Sobey; Grant R Drummond
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

8.  Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension.

Authors:  Heinrich E Lob; David Schultz; Paul J Marvar; Robin L Davisson; David G Harrison
Journal:  Hypertension       Date:  2012-12-17       Impact factor: 10.190

9.  Regulatory T cells ameliorate angiotensin II-induced cardiac damage.

Authors:  Heda Kvakan; Markus Kleinewietfeld; Fatimunnisa Qadri; Joon-Keun Park; Robert Fischer; Ines Schwarz; Hans-Peter Rahn; Ralph Plehm; Maren Wellner; Saban Elitok; Petra Gratze; Ralf Dechend; Friedrich C Luft; Dominik N Muller
Journal:  Circulation       Date:  2009-05-26       Impact factor: 29.690

10.  Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.

Authors:  Aline M Hilzendeger; Martin D Cassell; Deborah R Davis; Harald M Stauss; Allyn L Mark; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2012-12-24       Impact factor: 10.190

View more
  32 in total

Review 1.  Aging, arterial stiffness, and hypertension.

Authors:  Zhongjie Sun
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 2.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

3.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

4.  A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure.

Authors:  Hannu Turpeinen; Ilkka Seppälä; Leo-Pekka Lyytikäinen; Emma Raitoharju; Nina Hutri-Kähönen; Mari Levula; Niku Oksala; Melanie Waldenberger; Norman Klopp; Thomas Illig; Nina Mononen; Reijo Laaksonen; Olli Raitakari; Mika Kähönen; Terho Lehtimäki; Marko Pesu
Journal:  Hum Genet       Date:  2015-03-27       Impact factor: 4.132

5.  Genetic disruption of Npr1 depletes regulatory T cells and provokes high levels of proinflammatory cytokines and fibrosis in the kidneys of female mutant mice.

Authors:  Venkateswara Reddy Gogulamudi; Indra Mani; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

Review 6.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 7.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

Review 8.  Novel adaptive and innate immunity targets in hypertension.

Authors:  Justine M Abais-Battad; John Henry Dasinger; Daniel J Fehrenbach; David L Mattson
Journal:  Pharmacol Res       Date:  2017-03-20       Impact factor: 7.658

Review 9.  Role of immune cells in salt-sensitive hypertension and renal injury.

Authors:  Brittany Wade; Justine M Abais-Battad; David L Mattson
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

10.  Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013.

Authors:  Nwora Lance Okeke; Thibaut Davy; Joseph J Eron; Sonia Napravnik
Journal:  Clin Infect Dis       Date:  2016-04-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.